Save antibiotics. What can be done to prevent a forecasted disaster! Suggestions to promote the development of new antibiotics;Sauver les antibiotiques ! Que faire pour prévenir un désastre annoncé: propositions pour favoriser le développement de nouveaux antibiotiques

Medecine et Maladies Infectieuses

Volumn 40, Issue 3, 2010, Pages 129-134

  Tremolieres F ^a   Cohen, R ^b   Gauzit, R ^c   Vittecoq, D ^d   Stahl, J P ^e  

^a Francois Quesnay Hospital   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL PAUL BROUSSE   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic; Assessment method; Clinical trial

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; NEOMYCIN; STREPTOMYCIN; SULBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MARKETING; DRUG USE; FOOD AND DRUG ADMINISTRATION; FRANCE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRODUCT DEVELOPMENT; RISK ASSESSMENT; SHORT SURVEY; SYMPOSIUM;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUGS, INVESTIGATIONAL; HUMANS;

EID: 77950915949     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2010.01.007     Document Type: Short Survey

References (10)

1. Bad bugs, no drugs: as antibiotic R&D stagnates, a public health crisis brews. Alexandria VA. Infectious Diseases Society of America, 2004.
2. Norrby S.R., Nord C.E., Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005, 5:115-119.
3. Dellit T.H., Owens R.C., McGowan J.E., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.
4. European Academics Scientific Advisory Council (EASAC). Tackling antibiotic resistance in Europe: European Academics Scientific Advisory Council, 2007.
5. Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect 2006, 12(Suppl 5):25-34.
6. Cohen R. Approaches to reduce antibiotic resistance in the community. Pediatr Infect Dis J 2006, 25:977-980.
7. Ayanruoh S., Waseem M., Quee F., Humphrey A., Reynolds T. Impact of rapid streptococcal test on antibiotic use in a pediatric emergency department. Pediatr Emerg Care 2009, [Epub ahead of print].
8. Bonner A.B., Monroe K.W., Talley L.I., Klasner A.E., Kimberlin D.W. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003, 112:363-367.
9. http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispFo rm.aspx%3FID=444.
10. Trémolières F. Génériques et antibiotiques: questions pour une classe thérapeutiques pas comme les autres. Med Mal Infect 2002, 32(S2):97-102.